Skip to main content
Equibles
BLLN logo

BLLN · BillionToOne, Inc.

Track BLLN — free

Use BLLN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$99.39 -0.11 (-0.11%) At close · Sep 4
Rebalance outlook locked
Market Cap
$4.69B
Shares
47.19M

BLLN metrics

62 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$99.39
Market cap
$4.69B

Price action

19 metrics
Price change (1W)
+6.6%
Price change (30D)
+8.4%
Price change (3M)
+2.3%
Price change (6M)
+35.2%
Price change (YTD)
+21.4%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
92.1%
Beta
1.8
RSI (14D)
47.3
Price vs SMA 50
-12.6%
Price vs SMA 200
+4.4%
Avg volume (3M)
736,623
Relative volume
1.3
Average dollar volume
$80.79M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
47.19M

Valuation

12 metrics
P / E (TTM)
95.7
Trailing earnings · reciprocal yield 1.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
11.4×
reciprocal yield 8.8%
P / book
8.5
reciprocal yield 11.8%
FCF yield
0.7%
TTM · current market cap
Buyback yield
—
P / FCF
136.8
reciprocal yield 0.7%
P / operating cash flow
100.0
reciprocal yield 1.0%
Earnings yield
0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
71.3%
Operating margin
10.9%
Trailing 12 months
Net margin
9.5%
Gross profit (TTM)
$283.22M
Operating profit (TTM)
$43.30M
Net income (TTM)
$37.71M
Trailing 12 months
Diluted EPS (TTM)
$1.04
FCF margin
8.3%
Effective tax rate
0.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-21.43

Growth

11 metrics
Revenue growth YoY
+64.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$397.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+424.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
7.0%
Return on assets
5.2%
Debt / equity
—
Current ratio
11.7
EBITDA (TTM)
$50.23M
Free cash flow (TTM)
$33.17M
Quick ratio
11.3
Interest coverage
1,056.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$548.63M
Total assets
$729.70M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$45.35M
Capital expenditures (TTM)
$12.18M
R&D (TTM)
$59.21M
SG&A (TTM)
$180.71M
Stock compensation (TTM)
$25.54M
R&D / revenue
14.9%
Stock compensation / revenue
6.4%

Ownership (13F)

3 metrics
13F filers
157
13F filer change QoQ
+66
Institutional ownership
32.7%

Short interest

3 metrics
Short interest
4.1%
Latest settlement · 1.8 days to cover
Days to cover
1.8d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$32.88M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2070849 CUSIP 090168105 13F (30d) 120 filings 120 filers Visit website Investor relations